Cargando…

Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival

PURPOSE: Ovarian cancer is typically diagnosed at late stages, and thus, patients’ prognosis is poor. Improvement in treatment outcomes depends, at least partly, on better understanding of ovarian cancer biology and finding new molecular markers and therapeutic targets. METHODS: An unsupervised meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lisowska, Katarzyna M., Olbryt, Magdalena, Student, Sebastian, Kujawa, Katarzyna A., Cortez, Alexander J., Simek, Krzysztof, Dansonka-Mieszkowska, Agnieszka, Rzepecka, Iwona K., Tudrej, Patrycja, Kupryjańczyk, Jolanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869753/ https://www.ncbi.nlm.nih.gov/pubmed/27028324 http://dx.doi.org/10.1007/s00432-016-2147-y

Ejemplares similares

Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014)

Advances in ovarian cancer therapy
por: Cortez, Alexander J., et al.
Publicado: (2017)

Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
por: Tudrej, Patrycja, et al.
Publicado: (2019)

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
por: Tudrej, Patrycja, et al.
Publicado: (2018)

Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2022)

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2020)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Evaluation of the Role of ITGBL1 in Ovarian Cancer
por: Cortez, Alexander Jorge, et al.
Publicado: (2020)

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2010)

Global Gene Expression Profiling in Three Tumor Cell Lines Subjected to Experimental Cycling and Chronic Hypoxia
por: Olbryt, Magdalena, et al.
Publicado: (2014)

Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation
por: Olbryt, Magdalena, et al.
Publicado: (2017)

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2022)

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018)

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
por: Konopka, Bozena, et al.
Publicado: (2016)

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction
por: Kupryjánczyk, J, et al.
Publicado: (2000)

Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
por: Dudaladava, Volha, et al.
Publicado: (2006)

Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology
por: Kaban, Alpaslan, et al.
Publicado: (2018)

Unsupervised Learning for Automated Detection of Coronary Artery Disease Subgroups
por: Flores, Alyssa M., et al.
Publicado: (2021)

Prognostic stratification of molecularly and clinically distinct subgroup in children with acute monocytic leukemia
por: Liu, Li‐Peng, et al.
Publicado: (2020)

Unsupervised cluster analysis reveals distinct subgroups in healthy population with different exercise responses of cardiorespiratory fitness
por: Xie, Lin, et al.
Publicado: (2023)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
por: Felisiak-Golabek, Anna, et al.
Publicado: (2011)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
por: Vias, Maria, et al.
Publicado: (2023)

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
por: Renaud, Gabriel, et al.
Publicado: (2022)

Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy
por: Olbryt, Magdalena, et al.
Publicado: (2020)

Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme
por: Macios, Anna, et al.
Publicado: (2021)

Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells
por: Vydra, Natalia, et al.
Publicado: (2021)

Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis
por: Roufas, Constantinos, et al.
Publicado: (2021)

Distinct T cell receptor repertoire diversity of clinically defined high-grade serous ovarian cancer treatment subgroups
por: Lee, Sanghoon, et al.
Publicado: (2021)

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
por: McGee, Jacob, et al.
Publicado: (2017)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
por: Naso, Julia R., et al.
Publicado: (2020)

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial
por: Hurvitz, Sara A., et al.
Publicado: (2021)

Identifying novel subgroups in heart failure patients with unsupervised machine learning: A scoping review
por: Sun, Jin, et al.
Publicado: (2022)

OCT Angiography of the Choriocapillaris in Central Serous Chorioretinopathy: A Quantitative Subgroup Analysis
por: Cakir, Bertan, et al.
Publicado: (2019)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

The Effect of Radiotherapy on the Concentration of Plasma Lipids in Elderly Prostate Cancer Patients
por: Wolny-Rokicka, Edyta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gtrlnaocfq0ksrs7qlpi3s7gr7